DUBLIN--(BUSINESS WIRE)--The "Global Vaccines Market Analysis 2019" report has been added to ResearchAndMarkets.com's offering.
The Global Vaccines market is expected to reach $71.04 billion by 2026 growing at a CAGR of 8.7% from 2018 to 2026.
Factors such as rise in prevalence of diseases, increasing government initiatives towards immunization and increasing number of prospects from the developing economies are driving the market growth. Though, high cost of development and complexities related to manufacturing are projected to inhibit the growth of the market. Moreover, high growth prospects in emerging markets may provide ample opportunities for the market growth.
By technology, recombinant vaccines segment acquired significant growth in the market owing to less side-effect of these vaccines in comparison to conventional ones. They are largely used in animals for prevention of diseases such as pneumonia, foot and mouth disease, septicaemia and pox disease that will further support the business growth. Developments in the field of molecular biology and genetic engineering will positively impact the growth of market.
The key vendors mentioned are Emergent Biosolutions, Glaxosmithkline, Pfizer, Sanofi Pasteur, Merck, Medimmune, LLC (A Subsidiary of Astrazeneca), CSL Limited, Serum Institute of India, Johnson & Johnson, Mitsubishi Tanabe Pharma Corporation, Astellas Pharma, Panacea Biotec, Bavarian Nordic, Biological E and Daiichi Sankyo Company.
Key Questions Answered in this Report
- How this market evolved since the year 2016
- Market size estimations, forecasts and CAGR for all the segments presented in the scope
- Key Market Developments and financials of the key players
- Opportunity Analysis for the new entrants
- SWOT Analysis of the key players
- Fastest growing markets analysed during the forecast period
Key Topics Covered
1 Market Synopsis
2 Research Outline
3 Market Dynamics
3.1 Drivers
3.2 Restraints
4 Market Environment
5 Global Vaccines Market, By Patient Type
5.1 Introduction
5.2 Pediatric Patients
5.3 Adult Patients
6 Global Vaccines Market, By Type
6.1 Introduction
6.2 Monovalent Vaccines
6.3 Multivalent Vaccines
7 Global Vaccines Market, By Route of Administration
7.1 Introduction
7.2 Oral Administration
7.3 Intramuscular and Subcutaneous Administration
7.4 Injectable
7.5 Other Routes of Administration
8 Global Vaccines Market, By Indication
8.1 Introduction
8.2 Foot and Mouth Disease
8.3 Respiratory Syncytial Virus (RSV)
8.4 Cancer
8.5 Cholera
8.6 Human Papilloma Virus (HPV)
8.7 Influenza
8.8 Diphtheria, Pertussis, and Tetanus (DPT)
8.9 Meningococcal Disease
8.10 Hepatitis
8.11 Varicella
8.12 Herpes Zoster
8.13 Measles, Mumps, and Rubella (MMR)
8.14 Dengue
8.15 Rotavirus
8.16 Pneumococcal Disease
8.17 Polio
8.18 Disease
9 Global Vaccines Market, By Technology
9.1 Introduction
9.2 Attenuated Vaccines
9.3 Recombinant Vaccines
9.4 Inactivated & Subunit Vaccines
9.5 Toxoid Vaccines
9.6 Live Attenuated Vaccines
9.7 Conjugate Vaccines
10 Global Vaccines Market, By Distribution Channel
10.1 Introduction
10.2 Retail Pharmacies
10.3 Institutional Sale
10.4 Hospital Pharmacies
11 Global Vaccines Market, By End User
11.1 Introduction
11.2 Pediatric Vaccines
11.3 Traveler Vaccines
11.4 Adult Vaccines
10 Global Vaccines Market, By Geography
10.1 Introduction
10.2 North America
10.3 Europe
10.4 Asia Pacific
10.5 South America
10.6 Middle East & Africa
11 Strategic Benchmarking
12 Vendors Landscape
12.1 Emergent Biosolutions
12.2 Glaxosmithkline
12.3 Pfizer
12.4 Sanofi Pasteur
12.5 Merck
12.6 Medimmune, LLC (A Subsidiary of Astrazeneca)
12.7 CSL Limited
12.8 Serum Institute of India
12.9 Johnson & Johnson
12.10 Mitsubishi Tanabe Pharma Corporation
12.11 Astellas Pharma
12.12 Panacea Biotec
12.13 Bavarian Nordic
12.14 Biological E
12.15 Daiichi Sankyo Company
For more information about this report visit https://www.researchandmarkets.com/r/y1y6vk
